| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | COO, President of R&D | Mar 15, 2022 | Option Exercise | $15.79 | 2,607 | 41,165 | 120,708 | Mar 17, 2022, 05:56 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | COO, President, R&D | Feb 15, 2022 | Option Exercise | $13.35 | 5,053 | 67,458 | 126,217 | Feb 17, 2022, 08:51 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | COO, President, R&D | Mar 15, 2021 | Option Exercise | $27.73 | 1,354 | 37,546 | 128,368 | Mar 17, 2021, 07:27 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | COO, President, R&D | Feb 15, 2021 | Option Exercise | $28.97 | 4,848 | 140,447 | 132,603 | Feb 19, 2021, 08:10 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | COO, President, R&D | Sep 30, 2020 | Option Exercise | $25.14 | 7,382 | 185,583 | 111,950 | Oct 02, 2020, 08:31 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | COO, President of R&D | Mar 15, 2020 | Option Exercise | $15.50 | 1,354 | 20,987 | 101,832 | Mar 17, 2020, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | COO, President, R&D | Feb 15, 2020 | Option Exercise | $25.33 | 3,325 | 84,222 | 103,186 | Feb 19, 2020, 08:22 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Jan 15, 2020 | Option Exercise | $22.89 | 4,441 | 101,654 | 81,511 | Jan 17, 2020, 08:12 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Dec 14, 2019 | Option Exercise | $15.99 | 2,971 | 47,506 | 85,952 | Dec 17, 2019, 07:56 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Mar 14, 2019 | Option Exercise | $15.59 | 166 | 2,588 | 90,277 | Mar 18, 2019, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Mar 14, 2019 | Option Exercise | $4.20 | 666 | 2,797 | 90,443 | Mar 18, 2019, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Mar 15, 2019 | Option Exercise | $15.45 | 1,354 | 20,919 | 88,923 | Mar 18, 2019, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Feb 15, 2019 | Option Exercise | $17.69 | 1,510 | 26,712 | 89,777 | Feb 20, 2019, 09:33 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Jan 15, 2019 | Option Exercise | $20.19 | 4,466 | 90,169 | 75,537 | Jan 17, 2019, 08:55 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Dec 14, 2018 | Option Exercise | $19.91 | 4,260 | 84,817 | 80,003 | Dec 14, 2018, 09:23 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Mar 21, 2018 | Option Exercise | $2.55 | 666 | 1,698 | 84,263 | Mar 23, 2018, 09:13 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Feb 15, 2018 | Option Exercise | $31.75 | 1,509 | 47,911 | 83,597 | Feb 16, 2018, 07:44 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Jan 15, 2018 | Option Exercise | $34.50 | 4,327 | 149,282 | 73,356 | Jan 17, 2018, 09:51 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Dec 14, 2017 | Option Exercise | $32.15 | 3,229 | 103,812 | 77,683 | Dec 18, 2017, 08:26 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Dec 14, 2016 | Option Exercise | $16.70 | 3,229 | 53,924 | 31,812 | Dec 16, 2016, 07:32 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Aug 12, 2016 | Option Exercise | $6.60 | 666 | 4,396 | 35,041 | Aug 16, 2016, 08:16 PM |
Menu